- AstraZeneca Pharma Ind
AstraZeneca Pharma Ind Share Price
NSE: ASTRAZEN
|BSE: 506820
|Pharmaceuticals
₹9,490.50
-₹244.00 (-2.51%) Last updated on 19 Jun, 2025 | 11:34 ISTAstraZeneca Pharma Ind Overview
Market cap  ₹24,336 Crs | Open ₹9,680.50 | Prev. Close ₹9,734.50 |
Circuit range ₹11,681.00 - ₹7,788.00 | Day range ₹9,482.00 - ₹9,724.50 | Year range ₹6,069.70 - ₹10,691.00 |
Volume 20,004 | Avg. traded ₹9,604.41 | Revenue (12m) ₹1,716 Crs |
About AstraZeneca Pharma Ind
AstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. Its therapeutic offerings in CVRM business include heart failure, and chronic kidney disease indications for Forxiga (Dapagliflozin). Its approvals in oncology business include the use of Imfinzi (Durvalumab) in Biliary Tract Carcinoma, and use of Lynparza (Olaparib) in early breast cancer. The Company has a portfolio of oral antidiabetic drugs with presence in two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The Company’s DPP4 offering comprises of the brands of Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metformin).
AstraZeneca Pharma Ind Share Price Chart
Please wait...
AstraZeneca Pharma Ind Key Indicators
P/E ratio 210.29 | P/B ratio 32.1 | ROE 24.95% |
ROCE 33.94% | Dividend yield 0.32% | Debt/Equity ratio |
EPS 64.6 |
Investment Checklist: (4/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
AstraZeneca Pharma Ind Financial Ratios
Operating profit margin16.84% | Net profit margin12.4% |
ROE24.95% | ROA13.35% |
ROCE33.94% |
Quick ratio1.74 | Current ratio2.23 |
Interest coverage183.95 | Asset turnover1.08 |
Debt to Equity0 |
P/E ratio210.29 | P/B ratio32.1 |
EV / EBITDA58.36 | |
Dividend yield0.32% |
Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
| No data found | |||
Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
| No data found | |||
Balance Sheet
All values are in ₹ Crores (Cr)
No data available at the moment
AstraZeneca Pharma Ind Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
18-Jun-25 | ₹10,000.00 | ₹9,734.50 | -3.32% |
17-Jun-25 | ₹10,290.00 | ₹10,069.00 | -1.92% |
16-Jun-25 | ₹10,450.00 | ₹10,266.00 | -2.32% |
13-Jun-25 | ₹10,029.00 | ₹10,509.50 | |
12-Jun-25 | ₹9,960.00 | ₹10,195.00 | |
11-Jun-25 | ₹9,980.00 | ₹9,970.00 | -0.84% |
10-Jun-25 | ₹10,000.00 | ₹10,054.50 | -0.02% |
09-Jun-25 | ₹9,900.00 | ₹10,057.00 |
Corporate Actions
Dividend • ₹24/share
Ex date 05 Jul 2024
Dividend • ₹16/share
Ex date 14 Jul 2023
Stocks Similar to AstraZeneca Pharma Ind
Stock Name | Price | Change % |
|---|---|---|
| Aarti Drugs | ₹445.60 | -₹0.80 (-0.18%) |
| Caplin Point Lab | ₹2,050.00 | -₹38.80 (-1.86%) |
| Eris Lifesciences | ₹1,747.70 | -₹32.50 (-1.83%) |
| FDC Limited | ₹461.85 | -₹6.55 (-1.4%) |
| Glenmark Life Science | ₹1,000.50 | -₹4.30 (-0.43%) |
| Granules India | ₹486.60 | -₹8.30 (-1.68%) |
| Hikal | ₹360.70 | -₹4.85 (-1.33%) |
| Jubilant Ingrevia | ₹721.00 | +₹3.80 (0.53%) |
| Jubilant Pharmova | ₹1,140.00 | +₹16.70 (1.49%) |
| Procter & Gamble Health | ₹5,921.00 | -₹30.00 (-0.5%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| HDFC Bank | ₹1,937.70 | +₹3.80 (0.20%) |
| Indian Railway Tourism Corp | ₹751.60 | -₹8.10 (-1.07%) |
| Infosys | ₹1,619.90 | -₹13.00 (-0.8%) |
| ITC | ₹417.80 | +₹1.90 (0.46%) |
| JIO FIN SERVICES LTD | ₹285.80 | -₹2.35 (-0.82%) |
| Reliance | ₹1,435.50 | +₹5.40 (0.38%) |
| Tata Motors | ₹669.75 | -₹0.50 (-0.07%) |
| Tata Power | ₹389.70 | -₹3.70 (-0.94%) |
| TCS | ₹3,426.50 | -₹24.90 (-0.72%) |
| Wipro | ₹263.38 | +₹1.79 (0.68%) |
AstraZeneca Pharma Ind News
CNBC Television
AstraZeneca Pharma India appoints Praveen Rao Akkinepally as MD
CNBC
AstraZeneca Pharma India shares rise 8% after revenue, margin jump in Q4
CNBC Television
AstraZeneca Pharma India shares rise 8% after revenue, margin jump in Q4
Upstox
AstraZeneca Pharma India surrenders marketing authorisation of prostate cancer drug, shares rise 4%
Moneycontrol
AstraZeneca Pharma shares likely to break 4-day losing streak
Livemint
52 Week High Stocks Today on March 24, 2025
Livemint
52 Week Low Stocks Today on March 24, 2025
Upstox
Stock market today: Aavas Financiers, IndiGo and Camlin Fine Sciences hit 52-week high; check details
CNBC Television
AstraZeneca gets nod to import Lokelma for treating high potassium
Livemint
AstraZeneca to bring innovative medicines faster to India, says MD Panchal
FAQs on AstraZeneca Pharma Ind
What is the share price of AstraZeneca Pharma Ind today?
AstraZeneca Pharma Ind share price is ₹ 9,490.50 as on 19 Jun, 2025 | 11:34 IST.
What are the high & low stock price of AstraZeneca Pharma Ind today?
AstraZeneca Pharma Ind stock price hit a high of ₹ 9,724.50 and low of ₹ 9,482.00 as on 19 Jun, 2025 | 11:34 IST.
What is the market cap of AstraZeneca Pharma Ind?
The market cap of AstraZeneca Pharma Ind is ₹ 24,336.25 Crores as on 19 Jun, 2025 | 11:34 IST.
What are the the 52-week high and low share prices of AstraZeneca Pharma Ind stock on the NSE?
52-week high stock Price of AstraZeneca Pharma Ind is ₹ 10,691.00 and Low Price is ₹ 6,069.70 as on 19 Jun, 2025 | 11:34 IST.
What are the stock symbols of AstraZeneca Pharma Ind?
The stock symbol of AstraZeneca Pharma Ind is NSE: ASTRAZEN on the NSE, BSE: 506820 on the BSE, and the ISIN is INE203A01020.
Can I buy AstraZeneca Pharma Ind shares on Holidays?
No, shares of AstraZeneca Pharma Ind or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell AstraZeneca Pharma Ind shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of AstraZeneca Pharma Ind?
The PE and PB ratio of AstraZeneca Pharma Ind is 210.29 and 32.1 respectively, as on 19 Jun, 2025 | 11:34 IST.
What are the returns on AstraZeneca Pharma Ind shares?
The historical returns for AstraZeneca Pharma Ind shares are 55.9 for 1 year, 266.31 for 3 year and 197.03 for 5 year.